Document Detail


Effects of intravenous N-acetylprocainamide on hemodynamics and left ventricular function in man.
MedLine Citation:
PMID:  2436466     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
N-acetylprocainamide (NAPA) is the active metabolite of procainamide currently undergoing evaluation for its antiarrhythmic properties. Its effects on hemodynamic variables and on ventricular function in man are poorly defined. The effects of intravenously administered NAPA (18 mg/kg over 30 minutes; mean plasma level 40.2 +/- 6.2 micrograms/ml) on hemodynamics and left ventricular ejection fraction (LVEF) assessed by radionuclide ventriculography were therefore determined in 14 patients undergoing diagnostic cardiac catheterization. The peak effects of the drug with respect to most measured variables were seen at 30 minutes and were still apparent at 60 minutes. NAPA increased heart rate (3% at 10 minutes; p less than 0.01), decreased mean pulmonary arterial pressure (14%; p less than 0.05) and capillary wedge pressure (27%; p less than 0.01), decreased mean arterial pressure (12%; p less than 0.01), cardiac index (8%; p less than 0.01), LV dp/dtmax (9%; p less than 0.05), and stroke work index (17%; p less than 0.01). The LVEF increased 5% (p less than 0.05). There was a trend for the systemic vascular resistance to decrease, but this did not reach statistical significance. The data show that NAPA exerts relatively weak peripheral arteriolar and venodilator effects associated with a mild reduction in contractility and cardiac output but an increase in LVEF in patients with preserved ventricular function.
Authors:
M A Josephson; M Schwab; K Coyle; B N Singh
Related Documents :
18276196 - Wide-spread myocardial remodeling after acute myocardial infarction in rat. features fo...
22781056 - Definitions of the physical properties of pressure ulcers and characterisation of their...
22898206 - The role of oxygen-increased respirator in humans ascending to high altitude.
22340226 - Erythrocytic or serum hydrogen sulfide association with hypertension development in unt...
17714086 - Indices of vascular stiffness and wave reflection in relation to body mass index or bod...
21436206 - Effects of renin-angiotensin system inhibition on right ventricular function in patient...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  113     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1987 Apr 
Date Detail:
Created Date:  1987-04-27     Completed Date:  1987-04-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  952-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acecainide / pharmacology*
Adult
Aged
Blood Pressure / drug effects
Depression, Chemical
Heart Catheterization
Heart Ventricles / drug effects*
Hemodynamics / drug effects*
Humans
Male
Middle Aged
Myocardial Contraction / drug effects
Procainamide / analogs & derivatives*
Stroke Volume / drug effects
Ventricular Function
Chemical
Reg. No./Substance:
32795-44-1/Acecainide; 51-06-9/Procainamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prenatal testing for maternal serum alpha-fetoprotein.
Next Document:  Alpha-fetoprotein associated with islet cell tumors.